Keywords: astrazeneca, initiates, ph, iii, comparison, zactima, tarceva

AstraZeneca initiates Ph III comparison of Zactima and Tarceva

Article | 09 October 2006

Print This

Anglo-Swedish drug major AstraZeneca says it has initiated a Phase III trial comparing its anticancer agent Zactima (ZD6474) with Roche's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in